1. Academic Validation
  2. An improved synthesis of butyl 4-[(4-amino-5-chloro-2-methoxybenzoyl)amino]-1-piperidineacetate (AU-224)

An improved synthesis of butyl 4-[(4-amino-5-chloro-2-methoxybenzoyl)amino]-1-piperidineacetate (AU-224)

  • Chem Pharm Bull (Tokyo). 2001 Jun;49(6):788-90. doi: 10.1248/cpb.49.788.
J Sakaguchi 1 T Higashi T Azuma T Suzuki N Iwasaki N Kondo O Nagata H Kato M Hanaoka
Affiliations

Affiliation

  • 1 Research Division, Hokuriku Seiyaku Co., Ltd., Katsuyama, Fukui, Japan. jun.sakaguchi@hokuriku-seiyaku.co.jp
Abstract

A new and facile route for the synthesis of the novel gastrointestinal prokinetic butyl 4-[(4-amino-5-chloro-2-methoxybenzoyl)amino]-1-piperidineacetate (1b), which exhibited potent gastro- and colon-prokinetic activities by oral administration without significant side effects, was established. The key intermediate, butyl 4-amino-1-piperidineacetate (16), was prepared from commercially available 4-amino-1-benzylpiperidine (2) in a high yield with four steps. Compound 1b was prepared by condensation of commercially available 4-amino-5-choloro-2-methoxybenzoic acid (7) with 16 in 84% yield. This improved synthetic route was appropriate for large-scale synthesis of 1b.

Figures
Products